Drug Shortage Report for ZOVIRAX
| Report ID | 103039 |
| Drug Identification Number | 00886157 |
| Brand name | ZOVIRAX |
| Common or Proper name | Acyclovir Oral Suspension |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ACYCLOVIR |
| Strength(s) | 200MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | ORAL |
| Packaging size | 475 mL |
| ATC code | J05AB |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | |
| Actual start date | 2020-02-10 |
| Estimated end date | 2020-03-26 |
| Actual end date | 2020-02-28 |
| Shortage status | Resolved |
| Updated date | 2020-02-29 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2020-01-10 | English | Compare |
| v2 | 2020-01-10 | French | Compare |
| v3 | 2020-01-30 | English | Compare |
| v4 | 2020-01-30 | French | Compare |
| v5 | 2020-02-12 | English | Compare |
| v6 | 2020-02-12 | French | Compare |
| v7 | 2020-02-28 | English | Compare |
| v8 | 2020-02-28 | French | Compare |
| v9 | 2020-02-29 | English | Compare |
Showing 1 to 9 of 9